CMV: a warrior against leukemia?
In this issue of Blood, Green et al provide additional information supporting that cytomegalovirus (CMV) reduces leukemia relapse after allogeneic stem cell transplantation.
Karolinska University Hospital, Sweden.
Per
P
Ljungman
D003587:Cytomegalovirus / Q000502:physiology*; D003586:Cytomegalovirus Infections / Q000517:prevention & control*; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000517:prevention & control*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D010750:Phosphoproteins / Q000276:immunology*; D014763:Viral Matrix Proteins / Q000276:immunology*; D014775:Virus Activation
D010750:Phosphoproteins; D014763:Viral Matrix Proteins; C065418:cytomegalovirus matrix protein 65kDa